MedPath
NMPA Approval

Repotrectinib Capsules

国药准字HJ20240018

May 8, 2024

Drug Information

瑞普替尼胶囊

奥凯乐

胶囊剂

40mg

化学药品

May 8, 2024

May 7, 2029

Company Information

Applicant Company

PO Box 4000, Princeton, NJ 08543 United States of America

Manufacturing Company

Patheon Inc

2100 Syntex Court, Mississauga, Ontario L5N 7K9 CANADA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞普替尼胶囊 - NMPA 批准文号 | MedPath